Registration Dossier

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: well documented study similar to OECD guideline study

Data source

Reference
Reference Type:
publication
Title:
A 13-week subchronic oral toxicity study of L-serine in rats.
Author:
Kaneko I, Han L, Liu T, Li J, Zhao Y, Li C, Yi Y, Liang A, Hayamizu K.
Year:
2009
Bibliographic source:
Food Chem Toxicol. 2009 Sep;47(9):2356-60

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
L-serine
EC Number:
200-274-3
EC Name:
L-serine
Cas Number:
56-45-1
Molecular formula:
C3H7NO3
IUPAC Name:
L-serine
Details on test material:
- Substance type: pure substance
- Physical state: white crystalline powder
- Analytical purity: 99.2% as determined by HPLC
- Storage condition of test material: stored at room temeperature

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Beijing Weitonglihua experimental animal technique Co. Ltd
- Age at study initiation: 6 weeks
- Housing: 5 animals were housed in a bottom-meshed stainless cage
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 1 week

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-22°C
- Humidity (%): 40-70%
- Air changes (per hr): ~15 changes/h
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
individual dose volume of 10 ml/kg was calculated according to the latest measured body weight.
Duration of treatment / exposure:
13 weeks
Frequency of treatment:
test article was administered daily by gavage
Doses / concentrations
Remarks:
Doses / Concentrations:
500, 1500, 3000 mg/kg bw
Basis:
actual ingested
No. of animals per sex per dose:
10/sex/dose
Control animals:
yes
Positive control:
no

Examinations

Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily

BODY WEIGHT: Yes
- Time schedule for examinations: twice a week

FOOD CONSUMPTION: Yes

HAEMATOLOGY: Yes
- Time schedule for collection of blood: at the end of the experimental period
- Anaesthetic used for blood collection: Yes (phenobarbital sodium)
- Animals fasted: Yes
- Parameters checked: RBC, HGB, HCT, MCV, MCH, MCHC, WBC, PLT, differential counts of leukocytes, reticulocyte count

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: at the end of the experimental period
- Animals fasted: Yes
- Parameters checked: TP, ALB, GLU, T-CHO, TG, T-BIL, BUN, CRE, IP, AST, ALT, ALP, Na, K, Cl, Ca

URINALYSIS: Yes
- Time schedule for collection of urine: during the last 4 days of the administration period
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Yes
- Parameters checked: urobilinogen, occult blood, bilirubin, ketone body, glucose, protein, pH, nitrite, specific gracity, leukocytes, sodium, potassium, chloride

Sacrifice and pathology:
GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
Statistics:
Variance in data for urinary quantitative data, hematology, serum biochemistry, body weights, food consumption, and absolute and relative organ weights was checked for homogeneity by Bartlett’s test. If the variance was homogeneous, the data were further analyzed by one-way analysis of variance. If not, the Kruskal–Wallis test was applied. When statistically significant differences were observed, the Dunnett’s multiple test was employed to compare between control and treatment groups. The urinary qualitative data and histopathological changes were analyzed with the Kruskal–Wallis test followed by Mann–Whitney’s U-test. Probability values of p < 0.05 were considered significant.

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Haematological findings:
no effects observed
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
no effects observed
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
no effects observed

Effect levels

Dose descriptor:
NOEL
Effect level:
3 000 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
The NOEL for the test item is 3000 mg/kg bw.
Executive summary:

In a subchronic toxicity study similar to OECD TG 408 L-serine was administered to 10 Sprague-Dawley rats/sex/dose by oral gavage at dose levels of 0 (control), 500, 1500 and 3000 mg/kg bw. Even the highest dose of 3000 mg/kg bw produced no adverse effects and is therefore regarded as the NOEL.